FDA inspection
Rxhomeo Private Limited: FDA inspection ending May 19, 2023
FDA inspection 1209017 · Official Action Indicated (OAI) · Hyderabad
Key facts
| Inspection ID | 1209017 |
|---|---|
| Firm | Rxhomeo Private Limited |
| FEI number | 3005269310 |
| Address | Indradhanush, Abids, 4-1-424 To 426 Bank Street |
| City | Hyderabad |
| Country | India |
| Fiscal year | 2023 |
| Inspection end date | May 19, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data